Pricing Log in Create free account
Saturday 17 October 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cencora, Inc. (COR) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Cencora, Inc. (COR) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.1× (March 2020) to 0.2× (March 2026); the current reading is higher than 98% of that period. That is below the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.2× 27.19%
FY2024 0.2× 6.54%
FY2023 0.1× 14.70%
FY2022 0.1× (4.77%)
FY2021 0.1× 31.67%
FY2020 0.1× (0.58%)
FY2019 0.1× (23.03%)
FY2018 0.1× 4.39%
FY2017 0.1× (0.62%)
FY2016 0.1× (21.55%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.2× (11.98%)
Mar 2026 0.2× (1.50%)
Dec 2025 0.2× 10.81%
Sep 2025 0.2× (1.83%)
42 more quarters

Against its own ten years

Low 0.1× High 0.2×
Ten-year median 0.1×
Current reading's percentile 98

EV/Sales against peers

Company EV/Sales
HKPD Cellyan Biotechnology Co., Ltd compare n/m
COR Cencora, Inc. 0.2×
CAH Cardinal Health, Inc. compare 0.3×
MCK McKesson Corporation compare 0.3×
COSM Cosmos Health Inc. compare 0.4×
ACH Accendra Health, Inc. compare 0.9×
HSIC Henry Schein, Inc. compare 0.9×
AHG Akso Health Group Sponsored ADR compare 1.8×
FOCL FocalTherics compare 2.1×
Medical Distribution industry median 0.6×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on COR